LaFleur J, Hoop R, Korner E, et al. Predictors of early discontinuation of pegylated interferon for reasons other than lack of efficacy in United States Veterans with chronic hepatitis C. Gastroenterol Nurs 2015 Nov-Dec;38(6):417-28. PMID: 26626031.
LaFleur J. Knowledge Engineering for Decision Support in Osteoporosis - Final Report. (Prepared by the University of Utah College of Pharmacy under Grant No. K08 HS018582). Rockville, MD: Agency for Healthcare Research and Quality, 2015.
LaFleur J, Steenhoek CL, Horne J, et al. Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture. Ann Pharmacother 2015;49(5):506–14. PMID: 25712443.
LaFleur J, Rillamas-Sun E, Colón-Emeric CS, et al. Fracture rates and bone density among postmenopausal veteran and non-veteran women from the Women’s Health Initiative. Gerontologist 2016 Feb;56 Suppl 1:S78–90. PMID: 26768394.